Neurolief: Funding, Investors & Team (Sep 2026)
Neurolief is focused on providing relief to patients with mental health and neurological disorders through innovative neuromodulation technology. The company is made up of experts in neuroscience and neurotech, and they have created a groundbreaking non-invasive brain neuromodulation system that can target multiple neural pathways simultaneously to impact mood and pain regulation.
Neurolief has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Aug 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Neurolief Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Neurolief Funding Rounds
Neurolief Founders and Leadership Team
Contact details for the Neurolief team: 1 of 1 has an email address on file.
Start 14-day free trial →Neurolief Funding Compared to Other Biotechnology Startups
Neurolief's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neurolief in Biotechnology and Netanya
Companies Similar to Neurolief
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Neurolief Funding FAQs
What does Neurolief do?
Neurolief is focused on providing relief to patients with mental health and neurological disorders through innovative neuromodulation technology. The company is made up of experts in neuroscience and neurotech, and they have created a groundbreaking non-invasive brain neuromodulation system that can target multiple neural pathways simultaneously to impact mood and pain regulation.
How much funding has Neurolief raised?
Neurolief has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Aug 2025.
When did Neurolief last raise funding?
Neurolief's most recent funding round on record is an undisclosed round of $5.0M, announced in Aug 2025.
Who founded Neurolief?
FundedIQ lists Amit Dar (Founder) at Neurolief.
Where is Neurolief headquartered?
Neurolief is based in Netanya, HaMerkaz, Israel.
How many employees does Neurolief have?
Neurolief is in the 11-50 employee band.
How does Neurolief's funding compare to other Biotechnology startups?
Neurolief's latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Neurolief Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neurolief is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.